We speculate that the elimination of EWSR1–FLI1 in a limited group of tumor cells could reduce the proliferation of neighboring cells through the secretion of pro-senescent factors, thus amplifying the effect of a possible therapy aimed at permanently inactivating EWSR1–FLI1. The gene discussed is EWSR1; the disease is neoplasm.